Company Filing History:
Years Active: 2013-2015
Title: Soichi Ohta: Innovator in Pharmaceutical Chemistry
Introduction
Soichi Ohta is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to solving complex medical challenges.
Latest Patents
Soichi Ohta holds 2 patents that focus on groundbreaking pharmaceutical compounds. His latest patents include a purine derivative and an antitumor agent utilizing the same. This patent discloses a novel purine derivative, a composition thereof, and a method for treating tumors using this derivative. Specifically, it details a compound represented by a specific formula, along with its pharmaceutically acceptable salts, solvates, hydrates, or prodrugs. Another significant patent involves a pyrimidine derivative that has a cell-protecting effect. This invention aims to provide a prophylactic or therapeutic agent against nerve diseases, such as ischemic brain disease and neurodegenerative diseases. It also addresses the need for a cell-protecting agent that acts as an inhibitor of brain cell damage or death.
Career Highlights
Soichi Ohta is currently associated with Zenyaku Kogyo Kabushiki Kaisha, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health issues.
Collaborations
Throughout his career, Soichi Ohta has collaborated with notable colleagues, including Toshiaki Suzuki and Hideki Satoh. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
Soichi Ohta's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also has the potential to improve therapeutic options for patients.